Research Paper Volume 10, Issue 6 pp 1424—1441

Usefulness of bevacizumab-induced hypertension in patients with metastatic colorectal cancer: an updated meta-analysis

Figure 2. Overall forest plots of objective response rate (ORR), progression-free survival (PFS) and overall survival (OS) for bevacizumab-induced hypertension in patients with metastatic colorectal cancer.